Pharmaceutical Executive-10-01-2010

Pharmaceutical Executive
Pharm Exec Special Section (Features)

October 01, 2010

Brand managers choosing to advertise an anti-depressant on "Criminal Minds" may not be making the best choice. New methodologies reveal "Law & Order: Special Victims Unit" along with "The Bachelor" to be shows favored by depressives

Pharmaceutical Executive
Columns

October 01, 2010

Health reform requires detailed tracking and full disclosure of fees to docs for marketing and research

Pharmaceutical Executive

Tracking, monitoring, and trend evaluation is not enough. Companies must now do more than assess what happened and why.

Pharmaceutical Executive
Columns

October 01, 2010

An underutilized sales resource, pharmacies and their staffs can help lead to improved scrip fulfillment and increased business

Pharmaceutical Executive

Will Roche's precedent push the regulatory community to create standards that will level the playing field for all contenders?

Pharmaceutical Executive

A leading industry player speaks out on what is fueling success in the sector

Pharmaceutical Executive
Columns

October 01, 2010

A report by the European Commission aimed at exploring patent exploitation by Big Pharma winds up generating more angst than answers

Pharmaceutical Executive
From the Editor

October 01, 2010

Adam Smith's theory of the uncompromising market may set the tone for today's capitalism, but we forget that his first work,"The Theory of Moral Sentiments," made 'bettering the human condition' the basis from which all productive commerce flows.

Pharmaceutical Executive

Ethical behavior can be a bridge-builder in an era where Big Pharma needs to find new partners. Is it up to the challenge?

Pharmaceutical Executive

Innovating in R&D may not be such a complicated task. Consumers simply want to find the product that gets a job done right every time

Pharmaceutical Executive

Teams must adapt techniques to embrace new technologies in order to remain successful

Pharmaceutical Executive
Features

October 01, 2010

As Medicare, Medicaid, and the nation's web of private payers gain market power, how can pharma stay ahead of the cost-containment curve?

Pharmaceutical Executive
Columns

October 01, 2010

A clear, consistent approach to the competition can deliver big gains in market share; six decisions lead the way